Mount Sinai study identifies new gene variations associated with heart rate

Findings pinpoint 14 genetic targets in humans that may provide insight for the treatment of cardiovascular disease

2013-04-15

(Press-News.org) (New York, NY – April 14, 2013) – Through a collaborative genome-wide study on individuals, researchers have discovered 14 new genetic variations that are associated with heart rate. Since heart rate is a marker of cardiovascular health, these findings could provide a better understanding of genetic regulation of heart beat and is a first step towards identifying targets for new drugs to treat cardiovascular disease.

The study, titled, "Identification of Heart Rate-Associated Loci and Their Effects on Cardiac Conduction and Rhythm Disorders," was published online this week in the April issue of Nature Genetics. Led by researchers at the Icahn School of Medicine at Mount Sinai and the Medical Research Council Epidemiology Unit in Cambridge, UK, the collaboration involved 268 researchers from 211 institutions, as well as six large research consortia joined forces.

In order to gain new insights into the genetic regulation of heart rate, Dr. Ruth Loos, Director of the Genetics of Obesity and Related Metabolic Traits Program at the Charles Bronfman Institute for Personalized Medicine at Mount Sinai and honorary investigator at the Medical Research Council Epidemiology Unit and her team, spent three years working on a genome-wide association study using data from 181,171 participants from 65 studies during 2009-2012. "Without any prior hypothesis, we studied the entire human genome hoping to identify new genetic variations that no one before had even imagined would play a role in the regulation of heart rate," said Dr. Loos, senior author of the study. "This discovery is just the beginning of something new and exciting and can hopefully be used to identify new drugs that can be used for the treatment of heart rhythm disorders."

In a follow-up study, experimental down-regulation of gene expression was then conducted on fruit flies and zebra fish, to better understand how genetic variations might affect heart rate. These experiments identified 20 genes with a role in heart rate regulation, signal transmission, embryonic development of the heart, as well as cardiac disorders, such as dilated cardiomyopathy, congenital heart failure and sudden heart failure. "Our findings in humans as well as in fruit flies and zebrafish provide new insights into mechanisms that regulate heart rate," said Dr. Marcel den Hoed, post-doctoral fellow at the Medical Research Council Epidemiology Unit and lead author of the study.

The follow-up study also showed that a genetic susceptibility for higher heart rate is associated with altered cardiac conduction and a reduced risk of sick sinus syndrome, a common indicator for pacemaker implantation. "Our study tripled the number of genetic variations that are known to be associated with heart rate, some of which are also associated with other cardiovascular risk factors and with heart rhythm disorder," said Dr. Loos.

### About The Charles Bronfman Institute for Personalized Medicine

The Charles Bronfman Institute for Personalized Medicine (IPM) drives innovation in the data-driven and gene-based individualization of healthcare. The Institute's groundbreaking work led to the creation of the BioMeBiobank Program to enable innovation in personalized healthcare. Over 23,000 Mount Sinai patients have enrolled in the BioMe program, which helps them receive more targeted, personalized care in real-time – based on their own DNA – through Mount Sinai's electronic medical record (EMR) system. The EMR-linked personalized medicine system empowers participating BioMe patients by providing tailored information in data-driven, gene-based personalized healthcare. This information includes each enrolled patient's unique genetic information and clinical data.

Mount Sinai patients who enroll in the BioMe program also contribute to medical breakthroughs by consenting to make their DNA, genetic and clinical information available for medical research in a secure and de-identified manner.

IPM also provides participating healthcare professionals with education, tools and resources for up-to-date practice guidelines incorporating the latest gene-based information for personalized healthcare.

For more information, visit http://icahn.mssm.edu/research/institutes/institute-for-personalized-medicine

About The Mount Sinai Medical Center

The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School of Medicine at Mount Sinai is one of the leading medical schools in the United States. The Icahn School of Medicine is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty members in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.

The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation's oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation's top hospitals based on reputation, safety, and other patient-care factors. Mount Sinai is one of just 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and by U.S. News & World Report and whose hospital is on the U.S. News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.

For more information, visit http://www.mountsinai.org/. Find Mount Sinai on: Facebook: http://www.facebook.com/mountsinainyc
Twitter @mountsinainyc
YouTube: http://www.youtube.com/mountsinainy END

ELSE PRESS RELEASES FROM THIS DATE:

Recent climate, glacier changes in Antarctica at the 'upper bound' of normal

2013-04-15

In the last few decades, glaciers at the edge of the icy continent of Antarctica have been thinning, and research has shown the rate of thinning has accelerated and contributed significantly to sea level rise. New ice core research suggests that, while the changes are dramatic, they cannot be attributed with confidence to human-caused global warming, said Eric Steig, a University of Washington professor of Earth and space sciences. Previous work by Steig has shown that rapid thinning of Antarctic glaciers was accompanied by rapid warming and changes in atmospheric ...

Bacterial security agents go rogue

2013-04-15

CRISPR, a system of genes that bacteria use to defend themselves against viruses, has been found to be involved in helping some bacteria evade the mammalian immune system. The results are scheduled for publication Sunday, April 14 in Nature. CRISPR is itself a sort of immune system for bacteria. Its function was discovered by dairy industry researchers seeking to prevent phages, the viruses that infect bacteria, from ruining the cultures used to make cheese and yogurt. Bacteria incorporate small bits of DNA from phages into their CRISPR region and use that information ...

Gene sequencing project finds new mutations to blame for a majority of brain tumor subtype

2013-04-15

The St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high toll on patients. Researchers also found evidence the tumors are susceptible to drugs already in development. The study focused on a family of brain tumors known as low-grade gliomas (LGGs). These slow-growing cancers are found in about 700 children annually in the U.S., making them the most common childhood tumors of the brain and spinal cord. For patients whose ...

The tulip tree reveals mitochondrial genome of ancestral flowering plant

2013-04-15

The extraordinary level of conservation of the tulip tree (Liriodendron tulipifera) mitochondrial genome has redefined our interpretation of evolution of the angiosperms (flowering plants), finds research in biomed Central's open access journal BMC Biology. This beautiful 'molecular fossil' has a remarkably slow mutation rate meaning that its mitochondrial genome has remained largely unchanged since the dinosaurs were roaming the earth. Evolutionary studies make used of mitochondrial (powerhouse) genomes to identify maternal lineages, for example the human mitochondrial ...

Ordinary skin cells morphed into functional brain cells

2013-04-15

Researchers at Case Western Reserve School of Medicine have discovered a technique that directly converts skin cells to the type of brain cells destroyed in patients with multiple sclerosis, cerebral palsy and other so-called myelin disorders. This discovery appears today in the journal Nature Biotechnology. This breakthrough now enables "on demand" production of myelinating cells, which provide a vital sheath of insulation that protects neurons and enables the delivery of brain impulses to the rest of the body. In patients with multiple sclerosis (MS), cerebral palsy ...

Better batteries from waste sulfur

2013-04-15

A new chemical process can transform waste sulfur into a lightweight plastic that may improve batteries for electric cars, reports a University of Arizona-led team. The new plastic has other potential uses, including optical uses. The team has successfully used the new plastic to make lithium-sulfur batteries. "We've developed a new, simple and useful chemical process to convert sulfur into a useful plastic," lead researcher Jeffrey Pyun said. Next-generation lithium-sulfur, or Li-S, batteries will be better for electric and hybrid cars and for military uses because ...

Standard CT protocol for trauma patients leads to overutilization of imaging

2013-04-15

It is unnecessary to scan trauma patients based on a non-focused standard trauma CT protocol, if the patient is transferred for care after already undergoing a focused CT examination based on the patient's history and physical examination, a new study shows. The study, conducted at the University of Pittsburgh Medical Center reviewed the records of 100 patients who were transferred from another facility. "The standard trauma CT protocol for all level 1 and 2 trauma patients transferred to our facility includes a CT examination of the head, cervical spine, thoracic spine, ...

Picture this: A dramatic drop in wrong patient errors

2013-04-15

Adding a photo of a face to x-ray images can reduce "wrong-patient" errors five-fold, a new study finds. "X-rays can look alike, and if one patient's images are confused with another before the radiologist sees them, it can be difficult for the radiologist to determine there is a mismatch," said Dr. Srini Tridandapani, of Emory University and an author of the study. As part of the study, ten radiologists interpreted 20 pairs of radiographic images with and without photographs. Two to four mismatched pairs were included in each set of 20 pairs of images. When photographs ...

High glucose levels could impair ferroelectricity in body's connective tissues

2013-04-15

High sugar levels in the body come at a cost to health. New research suggests that more sugar in the body could damage the elastic proteins that help us breathe and pump blood. The findings could have health implications for diabetics, who have high blood-glucose levels. Researchers at the University of Washington and Boston University have discovered that a certain type of protein found in organs that repeatedly stretch and retract – such as the heart and lungs – is the source for a favorable electrical property that could help build and support healthy connective tissues. ...

La Jolla Institute's surprising finding could alter the face of dengue vaccine development

2013-04-15

SAN DIEGO – (April 15, 2013) As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design. The finding runs counter to current scientific understanding of the key cells that need to be induced to develop a successful dengue vaccine. La Jolla Institute scientist Alessandro Sette, Dr.Biol.Sci., and his team found that T cells, which are key disease-fighting ...